Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function

Clinical trial NCT04356989 · COMPLETED

Trial details

NCT number: NCT04356989
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Non-valvular Atrial Fibrillation (NVAF)

Start date: 2020-05-13
Primary completion: 2022-11-15
Enrollment: 493

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.